The current earnings forecast score of Soleno Therapeutics Inc is 6.36, ranking 331 out of 382 in the Biotechnology & Medical Research industry. The average price target is 110.00, with a high of 145.00 and a low of 75.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Soleno Therapeutics Inc's expected revenue for the next quarter?
Soleno Therapeutics Inc's expected revenue is 112.86M.
What is Soleno Therapeutics Inc's price target?
Analysts forecast that Soleno Therapeutics Inc's price target is USD 110.00, with the highest forecast at USD 145.00 and the lowest forecast at USD 75.00.
How have Soleno Therapeutics IncSLNO's recent earnings per share performed?
The market expectation was USD 0.60, while Soleno Therapeutics IncSLNO's earnings per share (EPS) for the previous quarter was USD 0.81. EPS for the next quarter is expected at USD 0.94.